| Pharmaceutical active ingredients: |
| Ranitidine Bismuth Citrate |
| Available forms, composition and doses of Zantac EFFERdose: |
| N / A |
| Zantac EFFERdose medical category: |
| Human:Antacids, antireflux agents and antiulcerantsHistamine H2-antagonists |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A02BA02 - Ranitidine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| GlaxoSmithKline |
| Related documents and information about Zantac EFFERdose: |
| Zantac prescribing information (PDF)Zantac injection prescribing information (PDF) |